Pamela Thayalan

Statistics

Publications

Citations

732

H-Index

Active since

2006

Affiliations

Novartis (Singapore)(Current)

Genomics Institute of the Novartis Research Foundation

Pamela Thayalan is an author at Novartis (Singapore) specializing in drug discovery, mycobacterium tuberculosis infection, and tuberculosis drug development.

Publications per year

2006–2013

Publications

A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy

Kévin Pethe, Patrícia Carvalho de Sequeira, Sanjay Agarwalla et al. · Nature Communications · 2010 · 308 citations · Full text

Pharmacy, Medicinal Chemistry, Microbiology +12

Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis

Srinivasa P. S. Rao, Suresh B. Lakshminarayana, Ravinder Reddy Kondreddi et al. · Science Translational Medicine · 2013 · 149 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

A High-Throughput Screen To Identify Inhibitors of ATP Homeostasis in Non-replicating <i>Mycobacterium tuberculosis</i>

Puiying A. Mak, Srinivasa P. S. Rao, Mai Ping Tan et al. · ACS Chemical Biology · 2012 · 122 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +13

Peptide Deformylase Inhibitors as Potent Antimycobacterial Agents

Jeanette Teo, Pamela Thayalan, David Beer et al. · Antimicrobial Agents and Chemotherapy · 2006 · 57 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Peptide deformylase inhibitors of Mycobacterium tuberculosis: Synthesis, structural investigations, and biological results

A. Pichota, Jeyaraj Duraiswamy, Zheng Yin et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 48 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +15

1–5 of 6